New study indicates that tRNA-based drug discovery technology selects anti-HIV bioactive compounds possessing novel antiviral action…

CARY, NC (December 14, 2010) – Trana Discovery, Inc., an infectious disease drug discovery technology company, today announced that a recent study sponsored by the National Institute of Allergy and Infectious Disease, part of the National Institutes of Health, affirms that bioactive compounds selected ...